proteinuria

Advertisement
Charlotte RobinsonAcute Kidney Injury | March 11, 2025
Do changes in UPCR during severe AKI episodes affect how serum creatinine levels change at the time of sample collection?
Charlotte RobinsonWCN 2025 | February 10, 2025
Interim APPLAUSE-IgAN data showed that iptacopan was superior to placebo at reducing proteinuria at nine months.
Charlotte RobinsonWCN 2025 | February 6, 2025
Zigakibart for treatment of IgA nephropathy (IgAN) was well tolerated, reduced proteinuria, and stabilized eGFR at 76 weeks.
Charlotte RobinsonASN Kidney Week 2024 | October 22, 2024
Even when levels are below the current KDIGO threshold, proteinuria in IgAN indicates a risk of kidney failure.
Charlotte RobinsonNephrology Times | July 5, 2024
SGLT2i are associated with a significant reduction of proteinuria, especially for patients with higher BMI.
Patrick DalyOncology | April 1, 2022
According to a study, published in ESMO Open, no biomarkers have been validated for predicting efficacy outcomes in ...
Victoria SochaAcute Kidney Injury | February 5, 2024
Patients with hospitalized with COVID-19 frequently develop acute kidney injury (AKI) and may require renal replacement ...
DocWire News EditorsKidney Transplantation | February 5, 2024
Proteinuria is known as independent risk factor for cardiovascular disease in kidney transplant recipients. However, ...
DocWire News EditorsNephrology Times | October 25, 2021
Achieving complete or partial remission of proteinuria is associated with better long-term outcomes in patients with ...
DocWire News EditorsNephrology Times | February 5, 2024
A study sought to discern whether reductions in proteinuria following treatment for focal segmental glomerulosclerosis ...
DocWire News EditorsIgA Nephropathy | October 25, 2021
A study sought to discern surrogate endpoints that could serve as robust predictors of treatment efficacy on long-term ...
DocWire News EditorsIgA Nephropathy | October 25, 2021
A study shows that sustained proteinuria is a strong predictor for the rate of progression of renal disease, and ...
Victoria SochaCOVID-19 and Kidney Disease | June 3, 2021
The SARS-CoV-2 virus is responsible for COVID-19, a disease that, despite predominant respiratory manifestations, has a ...
Victoria SochaAnemia and Kidney Disease | April 5, 2023
C-peptide, a marker of beta cell reserve, is associated with complications in patients with type 2 diabetes mellitus. ...
Victoria SochaNational Kidney Foundation 2020 | April 19, 2023
The Cure Glomerulopathy Network (CureGN) is a multi-center, prospective, observational study of patients with primary ...
Victoria SochaEnd-Stage Renal Disease | April 12, 2023
A key component in the evaluation of live kidney donor candidates is the risk factor of subsequent kidney failure in the ...
Victoria SochaNephrology Times | September 25, 2019
The Kidney Disease Screening and Awareness Program (KDSAP), working to increase early detection and improve awareness of ...
Advertisement